MMSI Stock: Price, Earnings History and SEC Filings
Merit Medical Systems, Inc. (MMSI) last traded at $86.24, down 7.66% on the latest session and up 0.0% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $1.01 against an analyst estimate of $0.93, a beat of 8.6%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
MMSI earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 29, 2026 | $1.01 | $0.93 | +8.60% |
| Jun 2026 | Jul 30, 2026 | $1.09 | $0.85 | +28.24% |
| Mar 2026 | Apr 30, 2026 | $0.85 | $0.73 | +16.44% |
| Dec 2025 | Feb 24, 2026 | $0.94 | $0.85 | +10.59% |
MMSI beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How MMSI reacts to earnings
Across its last 8 earnings releases, MMSI moved 4.7% on average the next session, in either direction. It rose after 3 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-29 | After close | -7.66% |
| 2026-07-30 | After close | +1.99% |
| 2026-04-30 | After close | -9.05% |
| 2026-02-24 | After close | -3.88% |
| 2026-01-08 | After close | -7.30% |
| 2025-10-30 | After close | +5.42% |
| 2025-07-30 | After close | +2.29% |
| 2025-07-11 | After close | -0.04% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
MMSI financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $1.5B | $128M | $216M | 8.5% | $2.13 |
| 2024 | $1.4B | $120M | $186M | 8.9% | $2.03 |
| 2023 | $1.3B | $94M | $111M | 7.5% | $1.62 |
| 2022 | $1.2B | $75M | $69M | 6.5% | $1.29 |
| 2021 | $1.1B | $48M | $119M | 4.5% | $0.84 |
| 2020 | $964M | -$10M | $119M | -1.0% | $-0.18 |
| 2019 | $995M | $5M | -$360000 | 0.5% | $0.10 |
| 2018 | $883M | $42M | $23M | 4.8% | $0.78 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for MMSI
- 10-Q · Oct 29, 2026
- 8-K · Oct 29, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Aug 20, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 10-Q · Jul 30, 2026
- 8-K · Jul 30, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- 8-K · May 19, 2026Officer or director change, Bylaw change, Shareholder vote
- 10-Q · Apr 30, 2026
- 8-K · Apr 30, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Apr 13, 2026Regulation FD disclosure, Financial statements and exhibits
- 8-K · Apr 1, 2026Regulation FD disclosure, Financial statements and exhibits
Insider filing activity
MMSI insiders filed 4 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
MMSI news
- MMSI Q3 deep dive: balanced organic growth, new acquisitions, and margin improvementNov 1, 2026 · finance.yahoo.com
- Merit Medical Shares In Focus After Earnings Beat And Higher 2026 GuidanceOct 31, 2026 · finance.yahoo.com
- Merit Medical Systems: A Solid Q3, While Adding New Growth EnginesOct 31, 2026 · seekingalpha.com
- Merit Medical (MMSI) Q3 2026 Earnings Call TranscriptOct 30, 2026 · fool.com
- DexCom Stock Up on Q3 Earnings & Revenue Beat, Margins RiseOct 30, 2026 · finance.yahoo.com
- Merit Medical Systems IncOct 30, 2026 · 247wallst.com
- Merit Medical Systems (MMSI) Stock Could Be Slightly Undervalued On Cash FlowOct 30, 2026 · finance.yahoo.com
- Merit Medical Systems (MMSI) Lifted Guidance, Is It A Bargain?Oct 30, 2026 · finance.yahoo.com
About Merit Medical Systems, Inc.
Merit Medical Systems, Inc. (MMSI) is a US-listed public company on Nasdaq. The SEC classifies its business as Surgical & Medical Instruments & Apparatus. It is incorporated in UT. Its fiscal year ends in December.